Publication Name	World Journal of Gastroenterology
Manuscript ID	92806
Country	Italy

Received	2024-02-06 08:02
Peer-Review Started	2024-02-06 08:02
To Make the First Decision
Return for Revision	2024-03-07 03:39
Revised	2024-03-08 10:24
Second Decision	2024-04-15 02:39
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-04-15 04:47
Articles in Press	2024-04-15 04:47
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-04-25 01:46
Publish the Manuscript Online	2024-05-05 10:12

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Expanding indications for chronic hepatitis B treatment: Is it really desirable to treat everyone?
Manuscript Source	Invited Manuscript
All Author List	Fabiola Di Dato and Raffaele Iorio
ORCID	Author(s) ORCID Number Fabiola Di Dato http://orcid.org/0000-0001-9915-8972 Raffaele Iorio http://orcid.org/0000-0002-7483-234X
Funding Agency and Grant Number
Corresponding Author	Raffaele Iorio, MD, Associate Professor, Department of Translational Medical Science, Section of Pediatrics, University of Naples Federico II, Via Pansini 5, Naples 80131, Italy. riorio@unina.it
Key Words	Hepatitis B virus; Interferon; Nucleos(t)ide analogues; Functional cure; Children
Core Tip	There is a growing trend to expand the indications for the treatment of chronic hepatitis B. Starting from the concept that current therapies for chronic hepatitis B are unable to completely eradicate hepatitis B virus infection, this editorial critically analyzes the long-term efficacy of the available therapies and the rationale for an extension of current indications.
Publish Date	2024-05-05 10:12
Citation	Di Dato F, Iorio R. Expanding indications for chronic hepatitis B treatment: Is it really desirable to treat everyone? World J Gastroenterol 2024; 30(17): 2294-2297
URL	https://www.wjgnet.com/1007-9327/full/v30/i17/2294.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i17.2294

Full Article (PDF)	WJG-30-2294-with-cover.pdf
Manuscript File	92806_Auto_Edited-YJP.docx
Answering Reviewers	92806-Answering reviewers.pdf
Audio Core Tip	92806-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	92806-Conflict-of-interest statement.pdf
Copyright License Agreement	92806-CrossCheck report.pdf
Non-Native Speakers of English Editing Certificate	92806-Language certificate.pdf
Peer-review Report	92806-Peer-review(s).pdf
Scientific Misconduct Check	92806-Bing-Li L-2.png
Scientific Editor Work List	92806-Scientific editor work list.pdf
CrossCheck Report	92806-CrossCheck.png
CrossCheck Report	92806-CrossCheck report.pdf